CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Director nominations · Other events
- 4 Gift CEO and Chairman gave 50,000 shares (gift)
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 9 of 14 · 277 filings